Relationship between elevated platelet volume and saphenous vein graft disease

Clinical and Investigative Medicine

Volumn 33, Issue 3, 2010, Pages

  Tavil, Yusuf ^a   Şen, Nihat ^a   Yazici, Hüseyin Uǧur ^a   Hizal, Fatma ^a   Açikgöz, Sadik Kadri ^a   Turfan, Murat ^a   Cengel, Atiye ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CORONARY ARTERY BYPASS GRAFT; FEMALE; GRAFT OCCLUSION; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; SAPHENOUS VEIN; THROMBOCYTE; TRANSPLANTATION;

AGED; BLOOD PLATELETS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; SAPHENOUS VEIN;

EID: 77953469753     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bourassa MG, Enjalbert M, Campeau L, et al. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol 1984; 53: 102-107
2. Frey RR, Bruschke AVG, Vermeulen FEE. Serial angiographic evaluation 1 year and 9 years after aorta-coronary bypass. A study of 55 patients chosen at random. J Thorac Cardiovasc Surg 1984; 87: 167-174
3. Grondin CM, Campeau L, Thornton JC, et al. Coronary artery bypass grafting with saphenous vein. Circulation 1989; 79:124-129
4. Fuster V, Chesebro JH. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation 1986;73: 227-232
5. Walts AE, Fishbein MC, Matloff JM. Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years' experience. Am Heart J 1987;114: 718-723
6. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97: 916-931
7. Pizzulli L, Yang A, Martin JF, et al. Changes in platelet size and count in unstable angina compared tostable angina or non-cardiac chest pain. Eur Heart J 1998;19: 80-84
8. Jagroop IA, Mikhailidis DP. Mean platelet volume isan independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2003;120:169-170
9. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157-161
10. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006;17:67-69
11. Hekimsoy Z, Payzin B, Ornek T, et al. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications 2004; 18: 173-176
12. Brown AS, Hong Y, de Belder A, et al. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 802-807
13. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993; 86: 739-742
14. Nadar SK, Blann AD, Kamath S, et al. Platelet indexes in relation to target organ damage in high-risk hypertensive patients. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004; 44: 415-422
15. Coban E, Ozdogan M, Yazcioglu G, et al. The mean platelet volume in patients with obesity. International Journal of Clinical Practise 2005;59:981-982
16. Tavil Y, Sen N, Yazici HU, et al. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res. 2006 Dec 1; [Epub ahead of print]
17. Campeau L, Enjalbert M, Lesperance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984;311:1329-1332
18. Hoff HF, Beck GJ, Skibinski CI, et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988; 77: 1238-1244
19. Steele P, Battock D, Pappas G, et al. Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts. Circulation. 1976;53:685-687
20. Latour JG, Trudel JR, Campeau L, et al. Platelet regeneration time and late occlusion of aortocoronary saphenous vein bypass grafts. Can Med Assoc J. 1980; 21;1390-1393
21. Aras D, Erbay AR, Maden O, et al. Evaluation of serum levels of solubilized adhesion molecules in patients with aortocoronary saphenous vein grafts.Coron Artery Dis. 2005;16:431-436
22. Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation 1989; 80: 1190-1197
23. Thompson CB, Jakubowski JA. The pathophysiology and clinical relevance of platelet heterogenity. Blood 1998;72:1-8
24. Martin JF, Trowbridge EA, Salmon G, et al. The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-460
25. Sewell R, Ibbotson RM, Philips R. High mean platelet volume after myocardial infarction: is it due consumption of small platelets? Br Med J 1984,289:1576-1580
26. Erhart S, Beer JH, Reinhart WH. Influence of aspirin on platelet count and volume in humans. Acta Haematol 1999;101:140-144
27. Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipo-protein cholesterol levels and lowdose anticoagulation on obstructive chenges in saphenous-vein coronaryartery bypass grafts. N Engl J Med 1997; 336:153-162